Cargando…

Recent advances in recurrent hepatocellular carcinoma therapy

Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer, accounting for 75%-85% of cases. Although treatments are given to cure early-stage HCC, up to 50%-70% of individuals may experience a relapse of the illness in the liver after 5 years. Research on the fundamental trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yu-Xue, Ning, Qi-Qi, Yang, Peng-Xiang, Guan, Yuan-Yue, Liu, Peng-Xiang, Liu, Meng-Lu, Qiao, Lu-Xin, Guo, Xiang-Hua, Yang, Tong-Wang, Chen, De-Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190692/ https://www.ncbi.nlm.nih.gov/pubmed/37206651 http://dx.doi.org/10.4254/wjh.v15.i4.460

Ejemplares similares

Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma
por: Dong, Jia-Mei, et al.
Publicado: (2023)

Recent advances in nutritional composition, phytochemistry, bioactive, and potential applications of Syzygium aromaticum L. (Myrtaceae)
por: Xue, Qing, et al.
Publicado: (2022)

Recent Advances in Synthesis of Benzothiazole Compounds Related to Green Chemistry
por: Gao, Xiang, et al.
Publicado: (2020)

Recent advances in proteolysis and peptide/protein separation by chromatographic strategies
por: Zhang, XiangMin, et al.
Publicado: (2010)

Recent Advances in Volatiles of Teas
por: Zheng, Xin-Qiang, et al.
Publicado: (2016)

Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
por: Li, Jiarui, et al.
Publicado: (2023)

Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection
por: Hu, Haoyu, et al.
Publicado: (2021)

Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma
por: Wang, Xiang-Kun, et al.
Publicado: (2020)

Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy
por: Lu, Zhan, et al.
Publicado: (2023)

Editorial: Recent advances and new biomarkers in ulcerative colitis
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
por: Lu, Zhan, et al.
Publicado: (2023)

Recent Perspectives on the Mechanism of Recurrence After Ablation of Hepatocellular Carcinoma: A Mini-Review
por: Yang, Jianquan, et al.
Publicado: (2022)

Recent research progress on the synthesis and biological effects of selenium nanoparticles
por: Zhang, Ting, et al.
Publicado: (2023)

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
por: Zhou, Kai-Qian, et al.
Publicado: (2020)

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
por: Xu, Weiqi, et al.
Publicado: (2019)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

Recent Advances in the Immunoassays Based on Nanozymes
por: Zhou, Lu, et al.
Publicado: (2022)

Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
por: Zhang, Wei, et al.
Publicado: (2017)

Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition
por: He, Shu-Jin, et al.
Publicado: (2017)

Isolated metastasis of hepatocellular carcinoma in the right ventricle
por: Zhang, Xin-tong, et al.
Publicado: (2019)

Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2023)

Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy
por: Ni, Hang-Hang, et al.
Publicado: (2022)

Recent advances in tendon tissue engineering strategy
por: Ning, Chao, et al.
Publicado: (2023)

Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma
por: Yang, Xihua, et al.
Publicado: (2023)

Recent Advances in Zinc Hydroxystannate-Based Flame Retardant Polymer Blends
por: Pan, Wei-Hao, et al.
Publicado: (2022)

Recent Advances in the Heterogeneous Photocatalytic Hydroxylation of Benzene to Phenol
por: Han, Weiwei, et al.
Publicado: (2022)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
por: Zhu, Gui‐Qi, et al.
Publicado: (2021)

Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
por: Liu, Ruiqi, et al.
Publicado: (2022)

Recent Progress on MOF‐Derived Heteroatom‐Doped Carbon‐Based Electrocatalysts for Oxygen Reduction Reaction
por: Ren, Qian, et al.
Publicado: (2017)

Recent Advances on the Applications of Luminescent Pb(2+)-Containing Metal–Organic Frameworks in White-Light Emission and Sensing
por: Wang, Li-Xin, et al.
Publicado: (2021)

Recent Advances in Two-Dimensional Spintronics
por: Hu, Guojing, et al.
Publicado: (2020)

Recent advances in hypervalent iodine(III)-catalyzed functionalization of alkenes
por: Li, Xiang, et al.
Publicado: (2018)

Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
por: Shen, Chen, et al.
Publicado: (2023)

Recent Progress of Chronic Stress in the Development of Atherosclerosis
por: Gao, Shang, et al.
Publicado: (2022)

Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial
por: Wen, Zhenyu, et al.
Publicado: (2023)

Recent advances on phylogenomics of gymnosperms and a new classification
por: Yang, Yong, et al.
Publicado: (2022)

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
por: Xie, Xin, et al.
Publicado: (2023)

Recent advances of eosinophils and its correlated diseases
por: Tao, Zhang, et al.
Publicado: (2022)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Recent advances in lipid nanovesicles for targeted treatment of spinal cord injury
por: Lu, Di, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v5ethcn7gu89op8dcrinmice19